Are Proton Pump Inhibitors Affecting Intestinal Microbiota Health?

Gastroenterology

Volumn 149, Issue 4, 2015, Pages 848-850

  Melgar, Silvia ^a   Nieuwdorp, Max ^b,c,d  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

BACTERIAL OVERGROWTH; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CLOSTRIDIUM DIFFICILE INFECTION; COLON FLORA; DISEASE PREDISPOSITION; EDITORIAL; ENTEROCOCCACEAE; HUMAN; INTESTINE FLORA; METAGENOME; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; STREPTOCOCCACEAE; BACTERIUM; DRUG EFFECTS; INTESTINE; MICROFLORA;

BACTERIA; HUMANS; INTESTINES; MICROBIOTA; OMEPRAZOLE; PROTON PUMP INHIBITORS;

EID: 84942309351     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.08.039     Document Type: Editorial

References (17)

1. H.J. Lin, Y.P. Hung, H.C. Liu, and et al. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C difficile colonization J Microbiol Immunol Infect 48 2015 183 189
2. D.E. Freedberg, N.C. Toussaint, S.P. Chen, and et al. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial Gastroenterology 149 2015 883 885
3. S.K. Ratuapli, T.G. Ellington, M.T. O'Neill, and et al. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth Am J Gastroenterol 107 2012 730 735
4. A. Tsuda, W. Suda, H. Morita, and et al. Influence of Proton-pump inhibitors on the luminal microbiota in the gastrointestinal tract Clin Transl Gastroenterol 6 2015 e89
5. C.T. Seto, P. Jeraldo, R. Orenstein, and et al. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility Microbiome 2 2014 42
6. D.H. Yoo, I.S. Kim, T.K. Van Le, and et al. Gut microbiota-mediated drug interactions between lovastatin and antibiotics Drug Metab Dispos 42 2014 1508 1513
7. E. van Nood, A. Vrieze, M. Nieuwdorp, and et al. Duodenal infusion of donor feces for recurrent Clostridium difficile N Engl J Med 368 2013 407 415
8. R.A. Britton, and V.B. Young Role of the intestinal microbiota in resistance to colonization by Clostridium difficile Gastroenterology 146 2014 1547 1553
9. C. Gälman, B. Angelin, and M. Rudling Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis Gastroenterology 129 2005 1445 1453
10. C.G. Buffie, V. Bucci, R.R. Stein, and et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile Nature 517 2015 205 208
11. S.A. Joyce, and C.G. Gahan The gut microbiota and the metabolic health of the host Curr Opin Gastroenterol 30 2014 120 127
12. P. Van den Abbeele, C. Grootaert, M. Marzorati, and et al. Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX Appl Environ Microbiol 76 2010 5237 5246
13. J.S. Bajaj, I.J. Cox, N.S. Betrapally, and et al. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function Am J Physiol Gastrointest Liver Physiol 307 2014 G951 957
14. K. Stronks, M.B. Snijder, R.J. Peters, and et al. Unravelling the impact of ethnicity on health in Europe: the HELIUS study BMC Public Health 13 2013 402
15. D.A. Morrow, and J.A. de Lemos Benchmarks for the assessment of novel cardiovascular biomarkers Circulation 115 2007 949 952
16. H. Mathur, M.C. Rea, P.D. Cotter, and et al. The potential for emerging therapeutic options for Clostridium difficile infection Gut Microbes 5 2014 696 710
17. L.P. Smits, K.E. Bouter, W.M. de Vos, and et al. Therapeutic potential of fecal microbiota transplantation Gastroenterology 145 2013 946 953